Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study.
- DOI
- 10.1002/epi4.70364
- Published
- 2026 Oct 9
- Container
- Epilepsia open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/epi4.70364,
title = {Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study.},
author = {Romozzi M and Burgalassi A and Ceriello F and Martino P and Sette G and Pistoia F and Placidi F and Centonze D and Pani L and Canonichesi J and Vollono C and Calabresi P and Albanese M and Iannone LF},
year = {2026},
journal = {Epilepsia open},
doi = {10.1002/epi4.70364},
url = {https://doi.org/10.1002/epi4.70364}
}RIS
TY - JOUR TI - Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study. AU - Romozzi M AU - Burgalassi A AU - Ceriello F AU - Martino P AU - Sette G AU - Pistoia F AU - Placidi F AU - Centonze D AU - Pani L AU - Canonichesi J AU - Vollono C AU - Calabresi P AU - Albanese M AU - Iannone LF PY - 2026 JO - Epilepsia open DO - 10.1002/epi4.70364 UR - https://doi.org/10.1002/epi4.70364 ER -
APA
M, R., A, B., F, C., P, M., G, S., F, P., F, P., D, C., L, P., J, C., C, V., P, C., M, A., & LF, I. (2026). Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study.. Epilepsia open. https://doi.org/10.1002/epi4.70364
Source records
- pubmed · retrieved 2026-11-10T11:53:49.680Z